Health
Sanofi CEO: mRNA is likely the ‘go-to’ vaccine tech for a pandemic, but the ‘bar is high’ in other diseases – FiercePharma
In the global COVID-19 vaccine race, mRNA vaccines quickly got out to the front of the pack and two reached distribution in less than a year. But their quick success…
In the global COVID-19 vaccine race, mRNA vaccines quickly got out to the front of the pack and two reached distribution in less than a year. But their quick success in COVID-19 doesn’t guarantee mRNA will replace traditional vaccine technologies across the industry, Sanofi CEO Paul Hudson told Barrons.
During a single-antigen pandemic, where speed is a key consideration, “I think we have to accept that … mRNA is probably the first go-to,” Hudson told the publication. But in disease areas where…
-
General17 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Noosa News23 hours agoFuel tanker driver killed in horror head-on crash near Blackbutt identified as beloved father-of-two
-
Business21 hours agoUp 20% in 2 days, are Codan shares a buy, hold or sell?
-
Noosa News21 hours agoPalestine protesters forced into last-minute reroute